Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chie Hirai

1PUBLICATIONS

6CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 05, 2026

Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study.

Manami Tada, Yuichiro Kikawa, Nobuhiro Shibata

Pageof 1

Frequent Collaborators

1 joint publications

Manami Tada

1 joint publications

Yuichiro Kikawa

1 joint publications

Nobuhiro Shibata

1 joint publications

Hirotsugu Yanai

1 joint publications

Masahiro Takada

1 joint publications

Tomoharu Sugie

Frequent Collaborators

1 joint publications

Manami Tada

1 joint publications

Yuichiro Kikawa

1 joint publications

Nobuhiro Shibata

1 joint publications

Hirotsugu Yanai

Top Related Videos

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

See more related videos

Top Related Videos

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

See more related videos